Summary

U.S., Europe, and Japan AI in Endoscopy Market – Scope of Report
TMR’s report on the U.S., Europe, and Japan U.S., Europe, and Japan AI in endoscopy market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the U.S., Europe, and Japan U.S., Europe, and Japan AI in endoscopy market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the U.S., Europe, and Japan U.S., Europe, and Japan AI in endoscopy market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the U.S., Europe, and Japan AI in endoscopy market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the U.S., Europe, and Japan U.S., Europe, and Japan AI in endoscopy market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the U.S., Europe, and Japan U.S., Europe, and Japan AI in endoscopy market. These serve as valuable tools for existing market players as well as for entities interested in participating in the U.S., Europe, and Japan U.S., Europe, and Japan AI in endoscopy market.

The report delves into the competitive landscape of the U.S., Europe, and Japan U.S., Europe, and Japan AI in endoscopy market. Key players operating in the U.S., Europe, and Japan U.S., Europe, and Japan AI in endoscopy market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the U.S., Europe, and Japan U.S., Europe, and Japan AI in endoscopy market profiled in this report.

Key Questions Answered in U.S., Europe, and Japan U.S., Europe, and Japan AI in endoscopy market Report
• What is the sales/revenue generated by polypropylene catalyst across all regions during the forecast period?
• What are the opportunities in the U.S., Europe, and Japan U.S., Europe, and Japan AI in endoscopy market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue U.S., Europe, and Japanly in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the U.S., Europe, and Japan market?

U.S., Europe, and Japan AI in Endoscopy Market – Research Objectives and Research Approach
The comprehensive report on the U.S., Europe, and Japan U.S., Europe, and Japan AI in endoscopy market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the U.S., Europe, and Japan U.S., Europe, and Japan AI in endoscopy market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the U.S., Europe, and Japan U.S., Europe, and Japan AI in endoscopy market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: U.S., Europe, and Japan AI in Endoscopy Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. U.S., Europe, and Japan AI in Endoscopy Market Analysis and Forecast, 2017-2031
5. Key Insights
5.1. Technological Advancements
5.2. Key Product/Brand Analysis
5.3. Key Industry Events (Mergers & Acquisitions, Partnerships, and Product Launches)
5.4. Total number of AI Endoscopy Devices Sold by Country
5.5. COVID-19 Impact Analysis
5.6. Impact of AI in Endoscopy on Different Type of Cancer Detection (Colon, Barrett’s Esophagus, Gastric)
6. U.S. AI in Endoscopy Market Analysis and Forecast
6.1. Introduction
6.1.1. Key Findings
6.2. Market Value Forecast, by Type, 2017-2031
6.2.1. Product
6.2.2. Service
6.3. Market Value Forecast, by CAD, 2017-2031
6.3.1. CADe
6.3.2. CADx
6.3.3. CADe/CADx
6.4. Market Value Forecast, by Application, 2017-2031
6.4.1. Polyps Detection
6.4.2. Bleeding Detection
6.4.3. Early Cancer Identification
6.4.4. Cancer Staging
6.4.5. Polyp Sizing
6.4.6. Others (Polyps Characterization, Quality Indicators, etc.)
6.5. Market Value Forecast, by End-user, 2017-2031
6.5.1. Hospitals
6.5.2. Ambulatory Surgical Centers
6.5.3. Specialty Clinics
6.6. Market Attractiveness Analysis
6.6.1. By Type
6.6.2. By CAD
6.6.3. By Application
6.6.4. By End-user
7. Europe AI in Endoscopy Market Analysis and Forecast
7.1. Introduction
7.1.1. Key Findings
7.2. Market Value Forecast, by Type, 2017-2031
7.2.1. Product
7.2.2. Service
7.3. Market Value Forecast, by CAD, 2017-2031
7.3.1. CADe
7.3.2. CADx
7.3.3. CADe/CADx
7.4. Market Value Forecast, by Application, 2017-2031
7.4.1. Polyps Detection
7.4.2. Bleeding Detection
7.4.3. Early Cancer Identification
7.4.4. Cancer Staging
7.4.5. Polyp Sizing
7.4.6. Others (Polyps Characterization, Quality Indicators, etc.)
7.5. Market Value Forecast, by End-user, 2017-2031
7.5.1. Hospitals
7.5.2. Ambulatory Surgical Centers
7.5.3. Specialty Clinics
7.6. Market Value Forecast, by Country/Sub-region, 2017-2031
7.6.1. Germany
7.6.2. U.K.
7.6.3. France
7.6.4. Italy
7.6.5. Spain
7.6.6. Rest of Europe
7.7. Market Attractiveness Analysis
7.7.1. By Type
7.7.2. By CAD
7.7.3. By Application
7.7.4. By End-user
7.7.5. By Country/Sub-region
8. Japan AI in Endoscopy Market Analysis and Forecast
8.1. Introduction
8.1.1. Key Findings
8.2. Market Value Forecast, by Type, 2017-2031
8.2.1. Product
8.2.2. Service
8.3. Market Value Forecast, by CAD, 2017-2031
8.3.1. CADe
8.3.2. CADx
8.3.3. CADe/CADx
8.4. Market Value Forecast, by Application, 2017-2031
8.4.1. Polyps Detection
8.4.2. Bleeding Detection
8.4.3. Early Cancer Identification
8.4.4. Cancer Staging
8.4.5. Polyp Sizing
8.4.6. Others (Polyps Characterization, Quality Indicators, etc.)
8.5. Market Value Forecast, by End-user, 2017-2031
8.5.1. Hospitals
8.5.2. Ambulatory Surgical Centers
8.5.3. Specialty Clinics
8.6. Market Attractiveness Analysis
8.6.1. By Type
8.6.2. By CAD
8.6.3. By Application
8.6.4. By End-user
9. Competition Landscape
9.1. U.S. Europe, and Japan AI in Endoscopy Market, Company Share Analysis (2022)
9.2. Company Profiles
9.2.1. Medtronic plc
9.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.1.2. Product Portfolio
9.2.1.3. Financial Overview
9.2.1.4. SWOT Analysis
9.2.1.5. Strategic Overview
9.2.2. Wision A.I.
9.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.2.2. Product Portfolio
9.2.2.3. Financial Overview
9.2.2.4. SWOT Analysis
9.2.2.5. Strategic Overview
9.2.3. Olympus Corporation
9.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.3.2. Product Portfolio
9.2.3.3. Financial Overview
9.2.3.4. SWOT Analysis
9.2.3.5. Strategic Overview
9.2.4. ENDOANGEL Medical Technology Co., Ltd.
9.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.4.2. Product Portfolio
9.2.4.3. Financial Overview
9.2.4.4. SWOT Analysis
9.2.4.5. Strategic Overview
9.2.5. Fujifilm Corporation
9.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.5.2. Product Portfolio
9.2.5.3. Financial Overview
9.2.5.4. SWOT Analysis
9.2.5.5. Strategic Overview
9.2.6. Pentax Corporation
9.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.6.2. Product Portfolio
9.2.6.3. Financial Overview
9.2.6.4. SWOT Analysis
9.2.6.5. Strategic Overview
9.2.7. NEC Corporation
9.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.7.2. Product Portfolio
9.2.7.3. Financial Overview
9.2.7.4. SWOT Analysis
9.2.7.5. Strategic Overview
9.2.8. Magentiq Eye
9.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.8.2. Product Portfolio
9.2.8.3. Financial Overview
9.2.8.4. SWOT Analysis
9.2.8.5. Strategic Overview
9.2.9. Waycen Inc.
9.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.9.2. Product Portfolio
9.2.9.3. Financial Overview
9.2.9.4. SWOT Analysis
9.2.9.5. Strategic Overview
9.2.10. Iterative Scopes
9.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.10.2. Product Portfolio
9.2.10.3. Financial Overview
9.2.10.4. SWOT Analysis
9.2.10.5. Strategic Overview